A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku gynecologic cancer unit study

Oncology Reports

Volumn 19, Issue 6, 2008, Pages 1551-1556

  Yokoyama, Yoshihito ^a   Takano, Tadao ^b   Nakahara, Kenji ^c   Shoji, Tadahiro ^d   Sato, Hirokazu ^e   Yamada, Hidekazu ^f   Yaegashi, Nobuo ^b   Okamura, Kunihiro ^b   Kurachi, Hiroshisa ^c   Sugiyama, Toru ^d   Tanaka, Toshinobu ^e   Sato, Akira ^f   Tase, Toru ^g   Mizunuma, Hideki ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^g Miyagi Cancer Center   (Japan)

Author keywords

Advanced uterine cervical carcinoma; Phase II multicenter trial; Radiotherapy; Weekly nedaplatin

Indexed keywords

COBALT 60; GRANULOCYTE COLONY STIMULATING FACTOR; NEDAPLATIN; SEROTONIN ANTAGONIST; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DIARRHEA; DISEASE COURSE; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INTRACAVITARY DRUG ADMINISTRATION; LEUKOPENIA; MULTICENTER STUDY; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROCTITIS; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA; GAMMA RADIATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVIX TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; GAMMA RAYS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 48849116972     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM and Mutch DG: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340: 1137-1143, 1999.
2. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL and Insalaco S: Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340: 1144-1153, 1999.
3. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL III, Walker JL and Gersell D: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340: 1154-1161, 1999.
4. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL and Liao SY: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic oncology group and southwest oncology group study. J Clin Oncol 17: 1339-1348, 1999.
5. Peters WA III, Liu PY, Barrett RJ II, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr and Alberts DS: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18: 1606-1613, 2000.
6. Ota K, Wakui A, Majima H, Niitani H, Inuyama Y, Ogawa M, Ariyoshi Y, Yoshida O, Taguchi T and Kimura I: Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)- platinum (II). Gan To Kagaku Ryoho 19: 855-861, 1992.
7. Kato T, Nishimura H, Yakushiji M, Noda K, Terashima Y, Takeuchi S, Takamizawa H, Suzuki M, Arai M and Ota M: Phase II study of 254-S (cis-diammine glycolato-platinum) for gynecological cancer. Gan To Kagaku Ryoho 19: 695-701, 1992.
8. Yoshinaga K, Niikura H, Ogawa Y, Nemoto K, Nagase S, Takano T, Ito K and Yaegashi N: Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix. Gynecol Oncol 104: 36-40, 2007.
9. Inuyama Y, Miyake H, Horiuchi M, Hayasaki K, Komiyama S and Ota K: An early phase II clinical study of cis-diammine glycolato-platinum, 254-S, for head and neck cancers. Gan To Kagaku Ryoho 19: 863-869, 1992.
10. Onishi Y, Nakamura T, Hatae M, Adachi S and Ogasawara T: Phase I study of weekly nedaplatin and radiation therapy for advanced cervical cancer. Proc ASCO 21: 111b, 2002.
11. Malfetano JH, Keys H, Cunningham MJ, Gibbons S and Ambros R: Extended-field radiation and cisplatin for stage IIB and IIIB cervical carcinoma. Gynecol Oncol 67: 203-207, 1997.
12. Fields AL, Anderson PS, Goldberg GL, Wadler S, Beitler J, Sood B and Runowicz CD: Mature results of a phase II trial of concomitant cisplatin/ pelvic radiotherapy for locally advanced squamous cell carcinoma of the uterine cervix, Gynecol Oncol 61: 416-422, 1996.
13. Kawase S, Okuda T, Ikeda M, Ishihara S, Itoh Y, Yanagawa S and Ishigaki T: Intra-arterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer. Gynecol Oncol 102: 493-499, 2004.
14. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D and Mutch DG: Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22: 872-880, 2004.
15. Ohno T, Kato S, Wakamatsu M, Noda S, Murakami C, Nakamura M and Tsujii H: Incidence and temporal pattern of anorexia, diarrhea, weight loss and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: Comparison with radiation therapy alone. Gynecol Oncol 103: 94-99, 2006.
16. Mitsuhashi A, Uno T, Tanaka N, Suzuki K, Tate S, Yamazawa K, Matsui H, Yamamoto S, Ito H and Sekiya S: Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma. Gynecol Oncol 96: 194-197, 2005.
17. Fu KK, Lam KN and Rayner PA: The influence of time sequence of cisplatin administration and continuous low dose rate irradiation (CLDRI) on their combined effects on a murine squamous cell carcinoma. Int J Radiat Oncol Biol Phys 11: 2119-2124, 1985.
18. Dewit L: Combined treatment of radiation and cis-diammine-dichloroplatinum (II): A review of experimental and clinical data. Int J Radiat Oncol Biol Phys 13: 403-426, 1987.
19. Nakamura Y, Hasegawa M, Hayakawa K, Mtsuura M, Suzuki Y, Nasu S, Yamakawa M, Mitsuhashi N and Niibe H: Induction of p53-dependent apoptosis in vivo by nedaplatin and ionizing radiation. Oncol Rep 7: 261-265, 2000.
20. Tanaka T, Yukawa K and Umesaki N: Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro. Eur J Gynaecol Oncol 28: 352-355, 2007.